Nutrient Uptake During Continuous Enteral Feeding

Background

The investigators have previously studied the uptake of dietary isotope-labeled phenylalanine and plasma amino acid concentrations in critically ill patients and healthy subjects. During continuous feeding, uptake was unexpectedly found to be highly variable over time. Due to infrequent sampling, the time course of variability could not be modeled mathematically. Also, the underlying physiological mechanisms remain unclear, though it is hypothesized that gastric emptying is a major factor determining temporal variability.

The study here described is a follow-up that includes serial abdominal ultrasound studies to measure gastric emptying, additional indicators/tracers to determine more detail of uptake vs. digestion/transport/metabolism, and makes use of more frequent sampling to allow for detailed mathematical modeling of temporal variability.

Experimental protocol

ICU patients:

• Standard care and treatment as per clinical routines
• Pre-experiment ongoing nutrition for ≥ 6 hrs by nasogastric feeding tube or gastrostomy (not postpyloric)
• Bed rest during experiment as feasible

Healthy subjects

• Keep dietary and training habits for ≥ 2 days before experiment start
• Overnight fast
• Bed rest during experiment as feasible
• Nasogastric feeding tube
• Arterial line in radial or ulnar artery

Nutrition, sampling, measurements

• Experimental nutrition by continuous infusion for 10 hrs
• Infusion rate corresponding to 25 kcal/kg body weight/day (calculated including metabolizable tracers/indicators)
• Arterial blood sampling (à 1 ml) every 5 min in pilot study (may adjust to 10 or 15 min depending on results of pilot study)
• Serial abdominal ultrasound for determination of gastric volume (pilot study will determine how often)

Experimental nutrition

• Commercially available feeding formula for ICU use (Fresubin® HP Energy or similar) with added phenylalanine and glucose indicators
• Intrinsically labeled protein: 13C-L-phenylalanine intrinsically labeled milk protein
• Nonmetabolisable phenylalanine analogue: D-phenylalanine
• Free amino acid tracer: stable isotope-labeled phenylalanine tracer (2H5-L-Phe)
• Non-metabolizable glucose analogue: 3-O-Methyl-d-glucose (3-OMG)
• Free glucose tracer: isotope labeled D-glucose

Analyses

• arterial plasma amino acid and glucose tracers as above
• arterial plasma 3-OMG
• arterial plasma aminograms
• arterial plasma glucose, insulin, c peptide

Inclusion criteria

(ICU patients):

• stable enteral nutrition of >80% of measured or calculated energy expenditure by nasogastric feeding tube or gastrostomy

Exclusion criteria

(ICU patients):

• enteral nutrition by postpyloric route such as jejunostomy or postpyloric tube
• remaining ICU stay expected < 12 hrs
• ongoing bleeding that requires surgery/intervention or transfusion of > 2 units red cells/24 hrs
• inability to use feeding tube or arterial line

Inclusion criteria

(healthy subjects):

• healthy volunteer

Exclusion criteria

(healthy subjects)

• any condition or medication affecting nutrition or metabolism